Skip to content
Subscribe

'Right-to-Try' Legislation Gives Terminally-Ill Patients New Hope

Published:

The Illinois General Assembly recently passed legislation that may open the gates for new medical treatments for patients who have received terminal diagnoses.

Introduced earlier this year by State Rep. Greg Harris (D-Chicago), House Bill 1335, also known as "Right-to-Try," allows terminally-ill patients to try new drugs that have not been approved by the Food and Drug Administration (FDA). Since drugs can take years to get the FDA's stamp of approval, Harris said the bill is a "last ray of hope" for those who have exhausted all other treatment options.

The legislation passed the Illinois House 114-1, and the Senate unanimously passed its version, SB 29, on Thursday.

Under this legislation, insurance companies would not be compelled to cover investigational and experimental drugs that have passed at least the first of three stages of clinical trials. Manufacturers would not be required to provide unapproved medications. It also protects doctors from being sued when obtaining such drugs for patients who desire them.

The legislation may also represent a loss of confidence in the FDA. As previously reported on IVN, the administration, which is also tasked with regulating 80 percent of the country's food supply, has failed to review over 1,000 ingredients put into foods sold in American grocery stores.

Praising the bipartisan nature of the effort, Illinois Policy, a fiscally conservative think tank, noted:

"Right-to-Try laws empower patients whose lives are on the line to become informed of the potential benefits and risks of all treatment options in order to determine the plan of care they feel is best for them.", ""

Kurt Altman of the Goldwater Institute, who advised the Illinois Legislature on these bills, said

However, not everyone supports the proposed measure.

Although acknowledging that these decisions should always be up to a patient and their physician, Dr. Christopher Daugherty of the University of Chicago's MacLean Center for Clinical Medical Ethics said, "I think it's far more likely that we'll do more harm than good" with this type of legislation.

If "Right-to-Try" becomes law, Illinois would become the sixth state to pass such a measure. Governor Bruce Rauner's office declined to comment on whether or not he will sign the bill into law. However, the Senate bill's chief cosponsor, Michael Connelly (R-Wheaton), said he is "fairly confident" Rauner will sign it.

Photo Credit: 18percentgrey / shutterstock.com

Adhere to the IVN etiquette

By posting a comment, you agree to adhere to our etiquette rules: No partisan attacks, no personal attacks, substantiate your sources, no self-promotion.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Republish this article

Republishing guidelines

Republish IVN articles for free. Independent Voter News articles may be republished online or in print under a Creative Commons BY-NC-ND 4.0 license, on these terms:

  1. Credit the author and IVN. Keep the byline ("By Author Name, Independent Voter News") and the attribution note at the end, which links to the original.
  2. Keep the meaning. You may update time and place references and apply your house style. You may trim for length, as long as the cuts don't change the meaning or misrepresent the author. Keep the headline. Mark any additions as your own (for example "Additional reporting by ...").
  3. Translations are welcome. Translate faithfully, add "Translated from English by [your outlet]", and tell us at editor@ivn.us.
  4. Keep the links, including the link to the original article.
  5. Keep the tracking image. The HTML includes a 1-pixel image that counts readers on your page. It collects no personal information.
  6. Photos and illustrations. Images credited to IVN may be used with this article only. Images credited to others (AP, Getty, Unsplash, Wikimedia and so on) stay under their owners' terms. Secure the rights or switch "Include images" off.
  7. Don't sell it. You can't sell our articles or sell ads specifically against them. Your normal site advertising is fine.
  8. No implied endorsement. Don't suggest that IVN or the author endorses you, your candidates or your causes, or that donations to you support IVN.
  9. Keep labels. Opinion or analysis pieces keep that label.
  10. Point search engines to the original. Where your CMS allows, set the canonical URL to the original IVN article.
  11. No bulk or automated republishing, and don't submit our articles to aggregators (Apple News, Google News, MSN) as your own.
  12. Corrections and removals. Update your copy when we correct it, and remove it promptly if we ask. We'll contact you at the email you give us.
  13. Questions or print republication: editor@ivn.us.

IVN staff: fill in who you're inviting above, then create the invite.

Preparing the article

'Right-to-Try' Legislation Gives Terminally-Ill Patients New Hope

Choose a format
  • HTML
  • Email HTML
  • Markdown
  • Formatted (.docx)
  • Plain text
  • WordPress blocks
  • PDF
Choose a platform

Photos credited to others need their owners' permission.

To for

Republishing somewhere else? Questions? editor@ivn.us